Emerging mRNA-based nanomedicines for cancer immunotherapy
Chinese Chemical Letters · 2026-08 · 113288
DOI: 10.1016/j.cclet.2026.113288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-08. Verfasst von Chenxi Yu und 6 weiteren Autor:innen. Die Arbeit nennt 204 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Science and Technology Major Project, Natural Science Foundation of Tianjin Municipality.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Key Research and Development Program of China
- National Science and Technology Major Project
- Natural Science Foundation of Tianjin Municipality
Zitieren
APA
Yu, C., Wu, X., Luo, S., Wang, H., Huang, C., Zhang, L., & Zhu, D. (2026). Emerging mRNA-based nanomedicines for cancer immunotherapy. Chinese Chemical Letters, 113288. https://doi.org/10.1016/j.cclet.2026.113288
Vancouver
Yu C, Wu X, Luo S, Wang H, Huang C, Zhang L, et al. Emerging mRNA-based nanomedicines for cancer immunotherapy. Chinese Chemical Letters. 2026:113288. doi:10.1016/j.cclet.2026.113288
BibTeX
@article{Yu2026,
author = {Yu, Chenxi and Wu, Xuetong and Luo, Shamei and Wang, Hanyong and Huang, Chenlu and Zhang, Linhua and Zhu, Dunwan},
title = {Emerging mRNA-based nanomedicines for cancer immunotherapy},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {113288},
doi = {10.1016/j.cclet.2026.113288}
}
EUVIMED